Catch up locals' news in English
2022-02-16T03:28:36.674Z
The Ministry of Health of Russia will soon issue permission to conduct clinical trials of a coronavirus drug based on antibodies to several strains of COVID-19. This was stated by Academician of the Russian Academy of Sciences, head of the Gamaleya Center of the Ministry of Health of Russia Alexander Gintsburg.
“A package of documents for obtaining permission for clinical trials has been submitted.
As far as I know, permission should be obtained in the near future, ”RIA Novosti quotes Gunzburg.
Earlier, Gunzburg said that the Gamaleya Center is preparing for clinical trials of a coronavirus vaccine based on the Omicron and Delta strains.
Source: russiart
